Mission
Pushing Protein Engineering to the very frontier by developing game-changing solutions to challenging problems in human, animal and enviromental health
Vision
Bringing innovative solutions to vaccinology
From computer design to the market
We create next-generation subunit vaccines by Protein Engineering based on modular protein scaffold technologies. All components are designed for a maximum immune response.
Antigen
Selection
Candidate antigens are identified by Bioinformatics analysis
In Silico
Optimization
Antigens are improved by AI to increase immunogenicity, thermostability and expression
Expression &
Purification
Recombinant antigens are produced at high yields
Functional
Enhancement
Produced antigens are coupled to protein scaffolds to boost the immune response
Clinical
Trials
Vaccines are tested in the field
The first problem
Ticks and tick-borne diseases are responsible for more than $14 Bn annual losses in livestock worldwide.
Existing vaccines show poor results, with extreme efficacy loss depending on circulating tick population, while acaricides create environmental pollution, multi-resistant strains and export barriers.
The first solution
A next-gen Nanovaccine with high efficacy and broad-spectrum protection against bovine ticks.
Our anti-tick vaccine technological advantages
State-of-the-art Protein Engineering allows for game-changing solutions
Safe
The vaccine has no harmful effects on immunized animals.
Eco-friendly
No chemical residues in meat or environment.
Easily Implementable
The vaccine can be used alongside other control strategies.
Potent formulation
The vaccine elicit a robust and highly specific immune response.
Versatile
The high sequence conservation allows for a worldwide application.
Adaptable
Our technology can quickly adapt to new tick species or to immune-escape variants.
High quality production
Recombinant antigens are produced at high purity degree.
High stability
The optimized antigen is very durable and resistant to degradation.
Native antigenic structure
Linear and conformational epitopes are recognized.
How the anti-tick vaccine works
Immunized cattle with our vaccine generates protective antibodies
Ticks feeding on immunized animals take antibodies against their gut proteins
Ticks are damaged reducing the engorgement, egg laying and hatching
Seasonal boosts are required to maintain the immunological protection
Development Stage
Our Team
PhD. Agustín Correa
Founder, Director
PhD. Matías Machado
Founder, COO
Vet. Manuela Cilintano
Technical Director
Lic. Ricardo López
Bioprocess Technician
MSc. Cecilia Silvarrey
I+D Technician
Sponsors
